526139 — Transgene Biotek Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Transgene Biotek, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	0.39	0.242	0.151	0.031	0.077
Net Total Accounts Receivable
Net Total Receivables	0.084	0.084	0.084	0.084	0.084
Total Inventory
Total Other Current Assets
Total Current Assets	6.82	6.53	6.98	8.94	11.1
Net Property, Plant And Equipment	22.1	20.3	18.5	17.6	16.7
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,668	1,569	1,471	1,424	1,423
Accounts Payable
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	137	142	92.1	105	111
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1,341	1,346	1,297	1,310	1,316
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	327	222	174	114	107
Total Liabilities & Shareholders' Equity	1,668	1,569	1,471	1,424	1,423
Total Common Shares Outstanding